Month: March 2026

MONTREAL, March 25, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSX: FLT) (OTCQB: TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”), a Canadian integrated aerospace and drone solutions provider delivering aerial intelligence, advanced training, and autonomous systems capabilities, today announced a strategic partnership with the University of Technology, Jamaica (“UTech, Jamaica”) to deliver advanced drone training and applied technology programs beginning in April 2026. The partnership expands Volatus Aerospace’s global training footprint and strengthens its presence in the Caribbean while supporting the development of skilled drone operators and applied technology specialists in regions increasingly adopting uncrewed aerial systems for disaster response, environmental monitoring, infrastructure management, and public safety...

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) — Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC”, together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce the issuance of 639,609 carbon credits from the Rwanda Cookstoves Project (the “Project”), marking the fourth issuance from the Project and the first issuance of carbon credits following the successful transition of the Project to Verra’s VM0050 methodology. Upon the purchase of required insurance, the carbon credits are expected to receive Carbon Offsetting and Reduction Scheme for International Aviation (“CORSIA”) eligible tagging, further strengthening the Project’s inventory of high-integrity, compliance-aligned carbon credits. The 639,609 carbon credits are...

CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) — Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively “Marvel” or the “Company”), a drug discovery company developing novel, therapeutics for autism spectrum disorder and related conditions is pleased to announce that it has selected Novotech as the contract research organization (“CRO”) for the Company’s upcoming Phase I for its lead drug candidate MB-204. Novotech is an internationally recognized full service CRO based in Australia, that was awarded the 2025 Global Biotechnology Contract Research Organization Company of the Year by Frost & Sullivan in recognition of its innovation, client-focused delivery, and global impact. “Having previously worked with Novotech on multiple clinical programs, I am pleased...

BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Jane Wright-Mitchell, Pharm.D., J.D., as Chief Legal Officer, effective immediately. “Jane has worked with Vera Therapeutics previously as a strategic legal consultant and brings a depth and breadth of experience in supporting companies through regulatory approvals, commercialization, and intellectual property management,” said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. “As we near the potential launch of our first-in-class dual BAFF/APRIL inhibitor for patients with IgA nephropathy, Jane’s expertise will further strengthen our foundation for sustainable...

COLUMBIA, Md, March 25, 2026 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR), (“Rekor” or the “Company”), a leader in developing and implementing cutting-edge roadway intelligence systems, announced today the appointment of Marc Segal as Technical Account Management Director of Rekor Command®, the Company’s real-time traffic operations and incident management platform. Based in Austin, Texas, Marc Segal is positioned at the center of one of the most active transportation innovation markets in the country. His operations base aligns closely with Rekor’s expanding presence in Texas, and the Rekor Command® product has a statewide blanket purchase order with the Texas Department of Transportation (TxDOT), enabling TxDOT districts statewide to deploy Rekor Command.® With a background as a former TxDOT employee...

Proven Digital Leader Brings Deep Authority in Restaurant Technology and In-Store Advertising to Accelerate CRI’s Evolution into a Software-First SaaS Platform LOUISVILLE, Ky., March 25, 2026 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it has hired Jackie Walker as Chief Experience Officer (“CXO”) effective March 30, 2026. Ms. Walker is a veteran digital transformation leader with more than 15 years of experience designing, operating, and scaling enterprise digital platforms at the intersection of customer experience, product vision, and commercial outcomes. Her appointment marks a pivotal shift for Creative Realities as the Company transitions into a software-first platform business...

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the “Company” or “Brixton”) is pleased to announce the third batch of results from its ongoing exploration at the wholly owned Langis Silver Project, located in the historic silver mining camp of Cobalt, Ontario, Canada. The 2026 drill campaign marks a significant milestone, targeting both infill and expansion of established high-grade silver zones. To date, a total of 8,282 metres across 43 drill holes has been completed in 2026 (Figure 8). This includes 9 holes previously reported (refer to News Release, March 10, 2026), 5 holes previously released (refer to News Release, March 18, 2026) and 4 holes for 649.80m reported herein. HighlightsHole LM-26-290 intersected ultra high-grade silver returning 82,334 g/t...

Toronto, Ontario, March 25, 2026 (GLOBE NEWSWIRE) — DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX“), a leader in the development of new classes of structured products, announces that its Board of Directors has approved the grant of 1,450,000 stock options (the “Options”) to eligible participants under its stock option plan (the “Plan”). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of $0.08 per common share, all in accordance with the Plan.  Of the Options granted, 700,000 Options were granted to insiders of DelphX, including members of the board and executive officers. About DelphX Capital Markets Inc. DelphX is a technology and financial services company focused on developing and distributing the next generation of...

NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it has withdrawn its application for the marketing authorization of blarcamesine in the EU as an add-on therapy for the treatment of early Alzheimer’s disease in adults, which had been under review by the European Medicines Agency (EMA). The decision to withdraw the application follows feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) indicating that it would not be in a position...

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) — Fredonia Mining Inc. (“Fredonia” or the “Company”) is pleased to announce that it has entered into engagements for market making services and investor relations and capital markets advisory services with dedicated and experienced professionals to enhance and maximize its capital markets presence as it advances exploration at its El Dorado-Monserrat gold/silver project in Santa Cruz, Argentina. Market Making Services On March 24, 2026, Fredonia engaged the services of ICP Securities Inc. (“ICP”) to provide automated market making services to the Company, including use of its proprietary algorithm, ICP Premium®, in compliance with the policies and guidelines of the TSX Venture Exchange (“TSXV”) and other applicable legislation. The Company will pay ICP a monthly fee of $7,500, plus applicable...